UNSPSC 51141553: Denzimol

This classification denotes an anticonvulsant agent with the molecular formula C19H20N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9C78O7JATH, chemically known as 1h-imidazole-1-ethanol, alpha-(4-(2-phenylethyl)phenyl)- but generally known as denzimol, which bears US NIH Compound Identifier 53626. European Medicines Agency schedules Denzimol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06980MIG.

UNSPSC 51141553 Denzimol is a Commodity code, but the recent state and local opportunity record tagged under it describes procurement of naloxone and drug deactivation systems rather than denzimol itself — a pharmaceutical product with a different therapeutic purpose and chemical composition. The mismatch suggests the code was misapplied to this solicitation. The opportunity shows no relevant recent activity under the denzimol code's actual scope.

Seminole County, Florida posted the only recent state and local solicitation associated with this code: an IFB for naloxone and safe drug deactivation systems (IFB 60459723LAS), with a response deadline of July 26, 2023. The county sought 1,900 units of naloxone and 800 deactivation systems annually for its community health initiatives, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Bidders were required to submit pricing electronically, include all shipping and delivery costs, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract included a two-year initial term with a one-year renewal option and a three-month probationary period. Potential FEMA funding introduced compliance requirements under the Clean Air Act and Federal Water Pollution Control Act.